EUVIMEDEUVIMED entdecken
Crossref

Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials

Thomas Briot, Christine Truffaut, Luc Le Quay, Anne Lebreton, Frederic Lagarce

Pharmaceutical Technology in Hospital Pharmacy · 2016

DOI: 10.1515/pthp-2016-0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Technology in Hospital Pharmacy, 2016. Verfasst von Thomas Briot und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitomycin C (MMC) is widely used in treatment of non-muscle invasive bladder cancer at a 1 mg/mL concentration, by intravesical instillation. MMC is also used as an ophthalmic procedure in glaucoma care mostly with 0.2 mg/mL concentration. To accelerate syringes provision, it could be interesting to demonstrate the stability of the drug, in order to be able to prepare the chemotherapeutic drug several hours before the chemotherapy administration. : A stability indicating HPLC-UV method was developed and validated according to the ICH guidelines. Concentrations of the MMC stored at 25 °C and 60 % of relative humidity and protected from light in polypropylene syringes (1 mg/mL and 0.2 mg/mL) or glass vials (1 mg/mL) were evaluated for 96 h and compared to the initial observed concentrations. : MMC stability was demonstrated in syringes and glass vials at 1 mg/mL only for 8 h in water for injections and for 10 h at 0.2 mg/mL in 0.9 % sodium chloride solutions, because relative concentrations (95 % confidence interval of the mean of 3 samples) were systematically over 90 % of the initial concentrations. After 96 h the relative concentrations were found below 80 % as compared to initial concentrations, thus indicating instability of these solutions. Degradation products were observed and remained below 3 %. : This study confirms that MMC solutions for ophthalmic application at 0.2 mg/mL or vesical instillation at 1 mg/mL have to be formulated extemporaneously to maintain the desired concentration.

Zitieren

APA

Briot, T., Truffaut, C., Quay, L. L., Lebreton, A., & Lagarce, F. (2016). Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials. Pharmaceutical Technology in Hospital Pharmacy. https://doi.org/10.1515/pthp-2016-0012

Vancouver

Briot T, Truffaut C, Quay LL, Lebreton A, Lagarce F. Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials. Pharmaceutical Technology in Hospital Pharmacy. 2016. doi:10.1515/pthp-2016-0012

BibTeX
@article{Briot2016,
  author = {Briot, Thomas and Truffaut, Christine and Quay, Luc Le and Lebreton, Anne and Lagarce, Frederic},
  title = {Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials},
  journal = {Pharmaceutical Technology in Hospital Pharmacy},
  year = {2016},
  doi = {10.1515/pthp-2016-0012}
}
Kostenlos starten →